# Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

> **NCT06671431** · — · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 578 (actual)

## Conditions studied

- Distal Cholangiocarcinoma
- Adjuvant Chemotherapy

## Interventions

- **DRUG:** Adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT06671431
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2024-10-01
- **Target enrollment:** 578 (ACTUAL)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671431, "Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06671431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*